Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 2/20 | 0.31 |
| ▸ | F10 | P00742 | 2/20 | 0.31 |
| ▸ | PLG | P00747 | 2/20 | 0.31 |
| ▸ | PLAT | P00750 | 2/20 | 0.31 |
| ▸ | PROC | P04070 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6223128 | 0.87 | CSF1R (0.31) | MAPT | |
| SCHEMBL7214526 | 0.84 | F2 (0.33) | MAPTF2F10PLGPLAT | |
| SCHEMBL7448318 | 0.81 | F10 (0.38) | F2F10PLGPLATPROC | |
| SCHEMBL7214401 | 0.81 | F10 (0.38) | F2F10PLGPLATPROC | |
| Trifluoroacetic Acid SCHEMBL7214366 | 0.79 | CSF1R (0.31) | F2 | |
| SCHEMBL7219265 | 0.75 | F2 (0.37) | MAPTF2F10PLGPLAT | |
| SCHEMBL7449196 | 0.75 | F2 (0.37) | MAPTF2F10PLGPLAT | |
| SCHEMBL7456514 | 0.74 | F10 (0.38) | F2F10PLGPLATPROC | |
| SCHEMBL7213494 | 0.74 | F10 (0.38) | F2F10PLGPLATPROC | |
| SCHEMBL6223127 | 0.72 | CSF1R (0.33) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6602864-B1 | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-08-05 | — | — | US | disclosed |
| EP-0944386-B1 | SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2002-09-18 | — | — | EP | disclosed |
| US-6281227-B1 | INHIBITORS OF THE ACTIVITY OF FACTOR XA. | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-08-28 | — | — | US | disclosed |